EORTC-06083-LG - HOVON 100 ALL

Clofarabine added to prephase and consolidation therapy in acute lymphoblastic leukemia in adults. A prospective randomized trial.
Trial StatusRecruiting
DatesDate of activation: 19-Dec-11
Data management at EORTCMailbox
Phase2-3
Randomized trialYes
TypeHemato-malign
Targeted Sample size-
Number of steps1
DrugMercaptopurine
Tioguanine
Clofarabine
Cytarabine
Daunorubicin
Doxorubicin
Etoposide
Leucovorin
Methotrexate
Prednisolone
Prednisone
Vinblastine
Vincristine
Vindesine
Dexamethasone
Study StaffJean-Pierre Marie (Study Coordinator) - Assistance Publique - H˘pitaux de Paris - Hopital Saint Antoine AP-HP, Paris
Stefan Suciu (Statistician) - EORTC Headquarters, Brussels
Liv Meert (Data Manager) - EORTC Headquarters, Brussels
Safaa Ramadan (Coordinating Physician) - EORTC Headquarters, Brussels
Gaetan de Schaetzen (Project Manager) - EORTC Headquarters, Brussels, gaetan.deschaetzen( at )eortc.be, +32 27741618
Type of cancerAcute Lymphocytic Leukemia
Participating GroupsHemato-Oncologie Volwassenen Nederland(Coordinating Group)
EORTC Leukemia Group
Centers authorized by EORTC Hopitaux Universitaires Bordet-Erasme - Institut Jules Bordet (Brussels, Belgium) - Inst. 101
Universitair Ziekenhuis Gent (Gent, Belgium) - Inst. 104
A.Z. St. Jan (Brugge, Belgium) - Inst. 109
ZNA Stuivenberg (Antwerpen, Belgium) - Inst. 113
ZNA Middelheim (Antwerpen, Belgium) - Inst. 114
Cliniques Universitaires Saint-Luc (Brussels, Belgium) - Inst. 121
Centre Hospitalier Regional De La Citadelle (Liege, Belgium) - Inst. 145
U.Z. Leuven - Campus Gasthuisberg (Leuven, Belgium) - Inst. 147
AZ Delta - H. Hartziekenhuis (Roeselare, Belgium) - Inst. 1200
Assistance Publique - H˘pitaux de Paris - Hopital Saint Antoine AP-HP (Paris, France) - Inst. 203
Jeroen Bosch Ziekenhuis ('s-Hertogenbosch, The Netherlands) - Inst. 22
Erasmus MC Cancer Institute - location Daniel den Hoed (Rotterdam, The Netherlands) - Inst. 302
Radboud University Medical Center Nijmegen (Nijmegen, The Netherlands) - Inst. 304
Vrije Universiteit Medisch Centrum (Amsterdam, The Netherlands) - Inst. 308
Onze Lieve Vrouw Gasthuis (Amsterdam, The Netherlands) - Inst. 309
Leiden University Medical Centre (Leiden, The Netherlands) - Inst. 310
Academisch Ziekenhuis Maastricht (Maastricht, The Netherlands) - Inst. 324
HagaZiekenhuis ('S Gravenhage - Den Haag, The Netherlands) - Inst. 330
University Medical Center Groningen (Groningen, The Netherlands) - Inst. 335
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT number
EudraCT2008-005798-36
Protocol documents in PDF
(requires password)
Study documentation
@
Back to Protocol section